Ticker
EYPTCompany Name
EYEPOINT PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -173.27M | $ -2.48 | 1 | 69.93M |
3/31/2025 | $ -144.94M | $ -2.08 | 1 | 69.77M |
12/31/2024 | $ -129.23M | $ -2.3 | 1 | 56.3M |
9/30/2024 | $ -102.3M | $ -1.88 | 1 | 54.45M |
6/30/2024 | $ -85.85M | $ -1.61 | 1 | 53.21M |
3/31/2024 | $ -77.73M | $ -1.47 | 1 | 52.91M |
12/31/2023 | $ -69M | $ -1.77 | 1 | 38.9M |
9/30/2023 | $ -97.43M | $ -2.54 | 1 | 38.34M |
6/30/2023 | $ -101.98M | $ -2.71 | 1 | 37.58M |
3/31/2023 | $ -97.78M | $ -2.61 | 1 | 37.49M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS
EBITDAPS for EYEPOINT PHARMACEUTICALS INC is calculated as follows: EBITDA [ $ -30.49M ] / (Shares WA [ 12.79M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -2.38 ]
Minimum
Dec 31, 2020
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.78K |
---|---|
min | $ -10.86 |
max | $ 13.95 |
average | $ 2.01 |
median | $ 0.99 |
std | $ 4.26 |